A Trial Comparing Morcellation With Electrical Resection for Removal of Uterine Polyps
Launched by BIRMINGHAM WOMEN'S NHS FOUNDATION TRUST · Jan 12, 2012
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
The miniaturisation of hysteroscopes and ancillary instrumentation coupled with enhanced visualisation has enabled hysteroscopic surgery to be performed in an outpatient setting without the need for general anaesthesia or inpatient hospital admission. The most common operative hysteroscopic procedure is endometrial polypectomy and the feasibility and acceptability of such approaches has been demonstrated. The procedure involves removing polyps from the uterine cavity. Over 90% of UK gynaecologists routinely recommend removal of endometrial polyps following diagnosis with the aim of treating...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Finding of a benign polyp on diagnostic hysteroscopy
- • Patient considered able to tolerate outpatient hysteroscopic polypectomy based upon the response to preliminary diagnostic hysteroscopy. NB. all polyps diagnosed at hysteroscopy will be considered feasible to remove in the outpatient setting regardless of size, location or number. Patient factor(s) will be the only exclusion criteria following the diagnosis of benign, uterine polyp(s).
- • Need for polypectomy
- • Written informed consent
- Exclusion Criteria:
- • • Hysteroscopic features suggesting malignant lesion
About Birmingham Women's Nhs Foundation Trust
Birmingham Women's NHS Foundation Trust is a leading healthcare organization dedicated to providing high-quality women's and neonatal services. Committed to advancing clinical research, the Trust plays a pivotal role in conducting innovative clinical trials that aim to improve health outcomes for women and their families. With a multidisciplinary approach, the Trust collaborates with various stakeholders to ensure rigorous scientific standards and ethical practices are upheld in all research initiatives. Its focus on patient-centered care and commitment to excellence positions Birmingham Women's NHS Foundation Trust as a key contributor to advancements in women's health and medical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, West Midlands, United Kingdom
Patients applied
Trial Officials
Thomas J Clark, MBChB
Principal Investigator
Birmingham Womens Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials